Coagulation Disorder Clinical Trials

6 recruiting

Coagulation Disorder Trials at a Glance

14 actively recruiting trials for coagulation disorder are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Houston, Toronto, and Chicago. Lead sponsors running coagulation disorder studies include Christian Haslinger, Cwm Taf University Health Board (NHS), and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse coagulation disorder trials by phase

About Coagulation Disorder Clinical Trials

Looking for clinical trials for Coagulation Disorder? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coagulation Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coagulation Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

Coagulation Disorder, BloodProlonged APTT
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1,500 enrolled16 locationsNCT07418099
Recruiting
Phase 4

SWIFT - SWIss Factor XIII Trial in PPH

Postpartum ComplicationCoagulation DisorderPostpartum Hemorrhage+2 more
Christian Haslinger988 enrolled9 locationsNCT06481995
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Inflammatory Bowel DiseasesHeart DiseasesAutoimmune Disease+5 more
University of Chicago1,200 enrolled1 locationNCT01280825
Recruiting
Phase 3

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Coagulation Disorder
Takeda328 enrolled64 locationsNCT05156983
Recruiting

Investigation of the Genetics of Hematologic Diseases

Diamond-Blackfan AnemiaDyskeratosis CongenitaFanconi Anemia+10 more
St. Jude Children's Research Hospital1,716 enrolled1 locationNCT02720679
Recruiting
Not Applicable

Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery

Adverse Drug EventFibrinolysis; HemorrhageBlood Coagulation Disorder+2 more
University of Ioannina150 enrolled1 locationNCT07164300
Recruiting

Transfusion Surveillance in Anaesthesia

AnesthesiaSide EffectBlood Coagulation Disorder+4 more
Erasme University Hospital50,000 enrolled1 locationNCT06403163
Recruiting

Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)

ThrombosisBlood Coagulation DisorderPlatelet Thrombus+2 more
Scientific Institute San Raffaele60 enrolled1 locationNCT03255928
Recruiting

The Utility of Thromboelastography in Traumatic Brain Injury

Traumatic Brain InjuryCoagulation Disorder
Shanghai 6th People's Hospital500 enrolled1 locationNCT04524637
Recruiting

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Blood Coagulation Disorders, InheritedThrombotic Disorder
The University of Texas Health Science Center, Houston1,000 enrolled2 locationsNCT00178594
Recruiting
Not Applicable

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Heart DiseasesVascular DiseasesFibrinolysis; Hemorrhage+2 more
Konkuk University Medical Center764 enrolled3 locationsNCT05806346
Recruiting

Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

Stroke, IschemicTransient Ischemic AttackCoagulation Disorder
Cwm Taf University Health Board (NHS)360 enrolled1 locationNCT05645081
Recruiting

The ENDOCARDITIS AUMC Data Collection

EndocarditisValve Disease, HeartCoagulation Disorder
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3,000 enrolled1 locationNCT05139589